Reporting owner · CIK 0001912570
Goin Kathleen
SEC Form 4 history across 1 companies, 30 transactions and 4 filings.
COOChief Operating OfficerPALVELLA THERAPEUTICS, INC.
Open-market transaction mix0% buys0 buys · 14 sales
Available history · May 20, 2026 – Oct 21, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$76.6kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$208kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$252kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedSEC filing ↗ | $19.5kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedSEC filing ↗ | $15.4kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$253kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$150kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$250kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedSEC filing ↗ | $19.5kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedSEC filing ↗ | $15.3kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$47.3kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$15.8kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$61.1kView disclosure → | |
PVLAPALVELLA THERAPEUTICS, INC. | Goin KathleenCOO | S · sale10b5-1 detectedSEC filing ↗ | -$303kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at PALVELLA THERAPEUTICS, INC. on Oct 21, 2026 valued at $76,600.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 4 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| May 2026 | 0 | 3 | $0.00 | $475,630.90 | -$475,630.90 |
| Aug 2026 | 0 | 5 | $0.00 | $654,790.90 | -$654,790.90 |
| Sep 2026 | 0 | 3 | $0.00 | $654,922.92 | -$654,922.92 |
| Oct 2026 | 0 | 3 | $0.00 | $537,307.38 | -$537,307.38 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$165.9K
Median P/S size$179.4K
Direct30
Indirect0
Oct 21, 2026exercise
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
22 observations · May 20, 2026 – Oct 21, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 21, 20260 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| May 20, 2026 | 2,154 | May 22, 2026 | View transaction |
| May 20, 2026 | 4,302 | May 22, 2026 | View transaction |
| May 20, 2026 | 939 | May 22, 2026 | View transaction |
| May 20, 2026 | 48 | May 22, 2026 | View transaction |
| May 20, 2026 | 0 | May 22, 2026 | View transaction |
| Aug 19, 2026 | 2,154 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 4,302 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 2,802 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 804 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 404 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 302 | Aug 20, 2026 | View transaction |
| Aug 19, 2026 | 0 | Aug 20, 2026 | View transaction |
| Sep 16, 2026 | 2,154 | Sep 18, 2026 | View transaction |
| Sep 16, 2026 | 4,302 | Sep 18, 2026 | View transaction |
| Sep 16, 2026 | 2,643 | Sep 18, 2026 | View transaction |
| Sep 16, 2026 | 1,654 | Sep 18, 2026 | View transaction |
| Sep 16, 2026 | 0 | Sep 18, 2026 | View transaction |
| Oct 21, 2026 | 2,165 | Oct 23, 2026 | View transaction |
| Oct 21, 2026 | 4,313 | Oct 23, 2026 | View transaction |
| Oct 21, 2026 | 2,270 | Oct 23, 2026 | View transaction |
| Oct 21, 2026 | 607 | Oct 23, 2026 | View transaction |
| Oct 21, 2026 | 0 | Oct 23, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Goin Kathleen Insider Activity FAQ
SEC Form 4 context
Who is Goin Kathleen?
Goin Kathleen is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001912570.
Which companies has Goin Kathleen reported transactions for?
PALVELLA THERAPEUTICS, INC.
When was Goin Kathleen's latest insider buy?
No open-market insider purchase is available for this period.
When was Goin Kathleen's latest insider sale?
sale at PALVELLA THERAPEUTICS, INC. on Oct 21, 2026 valued at $76,600.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.